Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Pilot Efficacy Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With PAH

NCT00086463 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00086463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00086463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Pilot Efficacy Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With PAH
Lead sponsor
Actelion
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2004
Completion date
January 31, 2006
Enrollment
60
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

ayerza syndrome, pulmonary arterial hypertension, pulmonary hypertension